FLGR-242 60mg — Vial Spec, Reconstitution Math & COA

High-Mass Lyophilized Format: What FLGR-242 60mg Provides

In enterprise-scale bio-analytical investigations and extended multi-well in vitro panels, smaller peptide masses frequently introduce operational inefficiencies and lot-to-lot variance. A 60mg single-vial unit of FLGR-242 is designed to streamline large-scale research projects by supplying an abundant quantity of highly purified peptide in a single lyophilized cake. This mass specification is engineered for research teams running continuous, parallel assays where consistent stock concentration across dozens of microplates is paramount.

When purchasing high-mass configurations, investigators eliminate the cumulative analytical error associated with opening, reconstituting, and pooling multiple smaller 1mg or 5mg vials. While standard research quantities serve targeted preliminary studies, the 60mg vial format serves laboratories conducting broad-spectrum target binding assays, receptor saturation assays, or longitudinal cell proliferation studies requiring continuous reagent delivery over several weeks.

Please note that PX1 Research maintains flexible catalog inventory to accommodate diverse project scales. If the 60mg unit is currently out of stock or designated for custom bulk fulfillment, researchers can explore our standard inventory options via the main FLGR-242 product page or consult our comprehensive catalog of research peptides to identify currently stocked mass configurations.

Technical Overview: FLGR-242 Molecular Target & Preclinical Class

FLGR-242 is a synthetic peptide derivative investigated within the domain of transforming growth factor-beta (TGF-β) superfamily regulation, specifically focusing on myostatin (GDF-8) and activin signaling pathways. Preclinical models indicate that compounds in this class interact with target ligands to modulate downstream SMAD2/3 phosphorylation, a primary biochemical cascade regulating skeletal muscle proteolysis and cellular hypertrophy.

In vitro data suggest that FLGR-242 acts as a localized neutralizer of negative growth regulators. By binding to specific epitopes on circulating or tissue-bound myostatin, the peptide prevents the ligand from engaging the Activin type IIB receptor (ActRIIB). Consequently, researchers utilize FLGR-242 to study intracellular signaling shifts, gene expression changes related to heavy-chain myosin synthesis, and metabolic alterations in cell culture models of muscle atrophy.

Understanding the molecular kinetics of FLGR-242 requires precise concentration control during laboratory administration. Because high-potency receptor interactions occur at nanomolar thresholds in preclinical assays, accurate concentration calculations following reconstitution of high-mass 60mg vials are critical for experimental validity.

Reconstitution Protocols for 60mg Mass Quantities

Reconstituting a 60mg cake of lyophilized peptide requires careful consideration of solvent volume, final stock concentration, and fluid dynamics within the vial. Because 60mg represents a substantial mass of solute, selecting the correct diluent volume—typically sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile normal saline (0.9% NaCl)—depends entirely on the target concentration needed for working laboratory solutions.

Below are the calculated concentrations achieved when reconstituting a single 60mg FLGR-242 vial using common diluent volumes:

• Reconstitution with 1.0 mL Diluent: Yields a final concentration of 60.0 mg/mL (60,000 µg/mL). This highly concentrated stock solution is ideal for high-density master stocks intended for immediate sub-aliquoting into freezer-safe microcentrifuge tubes.

• Reconstitution with 2.0 mL Diluent: Yields a final concentration of 30.0 mg/mL (30,000 µg/mL). This intermediate concentration provides an optimal balance between volumetric accuracy and ease of pipetting for secondary dilution series.

• Reconstitution with 3.0 mL Diluent: Yields a final concentration of 20.0 mg/mL (20,000 µg/mL). This dilution is preferred when working with automatic liquid handling systems that perform optimal volumetric transfers within the 10 µL to 100 µL window.

To ensure precise volumetric calculations across custom solvent volumes, lab personnel are encouraged to utilize our interactive reconstitution calculator. When reconstituting, direct the diluent stream down the inner glass wall of the vial rather than directly onto the lyophilized cake. Gently swirl the vial in a smooth circular motion until completely dissolved; never vortex or vigorously shake peptide solutions, as mechanical shear stress can denature tertiary molecular structures.

Laboratory Aliquoting & Freeze-Thaw Prevention

High-mass peptide formats like the 60mg FLGR-242 vial must be properly managed post-reconstitution to prevent chemical degradation. Repeated freezing and thawing of reconstituted peptide solutions induces structural stress, aggregation, and loss of biological activity due to cryo-concentration and localized pH changes during phase transitions.

Once the 60mg cake is fully dissolved into a primary stock solution, the entire volume should be immediately aliquoted into single-use, polypropylene low-binding microcentrifuge tubes. Aliquot volumes should be calculated to match the exact requirements of a single experimental batch or single-day assay run (e.g., 50 µL to 100 µL working volumes).

Each aliquot tube must be clearly labeled with the compound name, lot number, concentration, and date of reconstitution before being flash-frozen. Liquid nitrogen flash-freezing prior to storage at -80°C provides maximum long-term stability for working peptide aliquots, preventing ice crystal formation that could compromise peptide integrity.

Long-Term Vial Stability & Chemical Storage Parameters

Prior to reconstitution, the sealed 60mg FLGR-242 vial should be stored in a controlled laboratory environment. Lyophilized peptides are susceptible to atmospheric moisture, photolytic degradation, and thermal destabilization. PX1 Research packaging ensures hermetic seals with bromobutyl stoppers and flip-off aluminum caps to preserve vacuum integrity during transit and storage.

Recommended storage conditions for FLGR-242 fall into distinct categories based on timeline and physical state:

• Sealed Lyophilized Vials (Short-Term, < 6 Months): Store at 2°C to 8°C (refrigerated), protected from light exposure in dark storage boxes.

• Sealed Lyophilized Vials (Long-Term, > 6 Months): Store at -20°C to -80°C in a non-frost-free freezer. Avoid frost-free freezers as their automated temperature cycling introduces destructive thermal fluctuation.

• Reconstituted Working Aliquots: Store at -80°C for up to 6–12 months. Refrigerated reconstituted stock (2°C to 8°C) should be utilized within 7 to 14 days, provided sterile bacteriostatic diluent was employed.

Lot-Matched COA Protocols: HPLC & Mass Spectrometry Verification

At PX1 Research, analytical rigor is the foundation of every product we supply. Every lot of FLGR-242—regardless of vial mass specification—undergoes comprehensive analytical testing in an ISO 17025 accredited, independent testing laboratory. We do not rely on manufacturer self-certifications or generic template certificates.

Each lot-matched Certificate of Analysis (COA) documents two primary analytical methodologies:

1. High-Performance Liquid Chromatography (HPLC): Determines the chemical purity of the peptide. PX1 Research enforces a strict acceptance threshold of ≥98.0% purity, ensuring that synthesis side-products, truncated sequences, and residual protecting groups are minimized.

2. Liquid Chromatography-Mass Spectrometry (LC-MS): Confirms exact identity by measuring the molecular mass of the target compound. The resulting mass spectrum verifies that the target sequence matches theoretical calculations down to the atomic mass unit (amu).

Additionally, our research-grade peptides undergo strict endotoxin testing (LAL chromogenic assay) to verify levels remain below 0.01 EU/µg, preventing confounding inflammatory responses in delicate cell cultures. Researchers can review, verify, and download specific analytical reports for their active lot directly through our centralized COA verification portal.

Comparative Analysis: FLGR-242 vs. Related Myostatin Pathway Modulators

When designing preclinical assays targeting muscle hypertrophy and metabolic pathways, researchers often evaluate FLGR-242 alongside other established TGF-β inhibitors and growth factor analogues. Comparative studies assist in determining which signaling pathway antagonist is best suited for specific in vitro research paradigms.

For example, Follistatin-315 is a naturally occurring glycoprotein that non-selectively binds myostatin, activin A, and follistatin-like proteins. In contrast, FLGR-242 is an engineered peptide sequence designed for targeted ligand binding, minimizing off-target activin neutralization in select bioassays. Meanwhile, upstream metabolic targets are frequently studied using IGF-1 LR3, an altered insulin-like growth factor analogue that acts via the RTK/Akt pathway rather than SMAD inhibition.

Understanding these mechanistic distinctions enables investigators to select the precise tool—or combination of targeted compounds—to isolate specific intracellular events in cell culture models.

Determining Optimal Vial Sizing: 60mg vs. Standard Research Quantities

Choosing between a high-mass 60mg vial format and standard lower-mass options (such as 1mg, 2mg, or 5mg vials) depends on experimental scale, equipment capabilities, and budget optimization.

The 60mg vial format is ideal for high-throughput screening environments, automated robotic liquid handlers, continuous multi-animal preclinical studies, and institutions executing uniform long-term research protocols. The unit economics of 60mg bulk configurations lower the per-milligram reagent cost significantly, maximizing research budget efficiency.

Conversely, standard smaller vials are recommended for pilot studies, initial dose-response curve mapping, or laboratories without continuous access to ultra-low temperature (-80°C) storage infrastructure. Using smaller units minimizes the financial risk of solution contamination or degradation during infrequent testing schedules.

Sourcing Standards, Catalog Availability & Procurement Protocols

PX1 Research operates as a trusted USA-based supplier dedicated exclusively to supporting academic, biotechnology, and institutional research facilities. All our compounds are synthesized in state-of-the-art GMP-compliant facilities and stored under climate-controlled conditions in our California and Arizona logistics hubs.

Orders placed before standard cutoff times ship same-day (Monday through Friday) using temperature-stable protective packaging to maintain peptide stability during transit. Institutional procurement departments seeking high-volume orders or recurring contract supply can request tailored terms through our dedicated wholesale laboratory portal.

To explore detailed technical papers, compound structures, and biological mechanisms, visit our comprehensive PX1 research hub. All products supplied by PX1 Research are strictly intended for in vitro, laboratory, and preclinical analytical applications—never for human or veterinary use.